# Pharmacogenetic Testing at Community Pharmacy

> **NCT06210321** · NA · NOT_YET_RECRUITING · sponsor: **Chantal Csajka** · enrollment: 270 (estimated)

## Conditions studied

- Pharmacogenetic Testing

## Interventions

- **OTHER:** Prescription of escitalopram using pharmacogenetic testing

## Key facts

- **NCT ID:** NCT06210321
- **Lead sponsor:** Chantal Csajka
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-15
- **Primary completion:** 2027-08-14
- **Final completion:** 2027-08-14
- **Target enrollment:** 270 (ESTIMATED)
- **Last updated:** 2025-06-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06210321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06210321, "Pharmacogenetic Testing at Community Pharmacy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06210321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*